YKL-40 in serum: a promising biomarker of juvenile SLE and strongly correlated with disease duration

Adult systemic lupus erythematosus in Egypt: The nation-wide spectrum of 3661 patients and world-wide standpoint

(2021) Tamer A Gheita et al.   LUPUS

Biomarkers Associated with Organ-Specific Involvement in Juvenile Systemic Lupus Erythematosus

(2021) James Greenan-Barrett et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Editorial: Traumatic Brain Injury and Autoimmune Disease

(2021) Sharon Baughman Shively et al.   Frontiers in Neurology

High YKL-40 serum levels and its expression in the muscle tissues of patients with antisynthetase syndrome

(2021) Renata Casseb de Souza Carboni et al.   Advances in Rheumatology

Macrophage Polarization and Plasticity in Systemic Lupus Erythematosus

(2021) Mariame Mohamed Ahamada et al.   Frontiers in Immunology

Patterns of microRNAs 142-3p, 106a, 17 and 20a expression in patients with systemic lupus erythematosus

(2021) Hecham Gamal AlDeen et al.   Egyptian Rheumatologist

Comparison of serum cytokine profiles in macrophage activation syndrome complicating different background rheumatic diseases in children

(2020) Mao Mizuta et al.   RHEUMATOLOGY

Serum YKL-40 level is associated with severity of interstitial lung disease and poor prognosis in dermatomyositis with anti-MDA5 antibody

(2019) Lili Jiang et al.   CLINICAL RHEUMATOLOGY

Glycoprotein YKL-40 Is Elevated and Predicts Disease Severity in Puumala Hantavirus Infection

(2019) Tuula K. Outinen et al.   Viruses-Basel

2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus

(2019) Martin Aringer et al.   Arthritis & Rheumatology

The contribution of macrophages to systemic lupus erythematosus

(2019) Chunyan Ma et al.   CLINICAL IMMUNOLOGY

Implications of macrophage polarization in autoimmunity

(2018) Samanta C. Funes et al.   IMMUNOLOGY

Elevated serum YKL-40 correlates with clinical characteristics in patients with polymyositis or dermatomyositis

(2018) Ming-Zhu Gao et al.   ANNALS OF CLINICAL BIOCHEMISTRY

Identification of alterations in macrophage activation associated with disease activity in systemic lupus erythematosus

(2018) Adam C. Labonte et al.   PLoS One

Clinical Utility of YKL-40 in Polymyositis/dermatomyositis-associated Interstitial Lung Disease

(2017) Hironao Hozumi et al.   JOURNAL OF RHEUMATOLOGY

Glycoprotein YKL-40: A potential biomarker of disease activity in rheumatoid arthritis during intensive treatment with csDMARDs and infliximab. Evidence from the randomised controlled NEO-RACo trial

(2017) Tuija Väänänen et al.   PLoS One

The inflammatory role of phagocyte apoptotic pathways in rheumatic diseases

(2016) Carla M. Cuda et al.   Nature Reviews Rheumatology

YKL-40 is a serum biomarker reflecting the severity of cutaneous lesions in psoriatic arthritis

(2013) Yasutomo Imai et al.   JOURNAL OF DERMATOLOGY

Role of Chitin and Chitinase/Chitinase-Like Proteins in Inflammation, Tissue Remodeling, and Injury

(2011) Chun Geun Lee et al.   Annual Review of Physiology

Astrocyte and Macrophage Regulation of YKL-40 Expression and Cellular Response in Neuroinflammation

(2011) Dafna Bonneh-Barkay et al.   BRAIN PATHOLOGY

YKL-40 Expression in Traumatic Brain Injury: An Initial Analysis

(2010) Dafna Bonneh-Barkay et al.   JOURNAL OF NEUROTRAUMA

Chitinase 3-Like-1 (CHI3L1): A Putative Disease Marker at the Interface of Proteomics and Glycomics

(2008) Frederick D. Coffman   CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES